|1||NCT03301090||Not yet recruiting||A Safety, Tolerability, Pharmacokinetics and Immunogenicity Trial of Co-administered MERS-CoV Antibodies REGN3048 and REGN3051||
||48||All||18 Years to 45 Years (Adult)||NCT03301090||15-0109
|February 28, 2018||September 1, 2018||January 1, 2019||October 4, 2017||December 25, 2017||
|2||NCT01056185||Recruiting||Respiratory Virus Hospitalization Study (FLU 003 Plus)||
||Other / NIH||
||1000||All||18 Years and older (Adult, Senior)||NCT01056185||0603M83587 FLU 003||August 2009||December 2017||December 2017||January 26, 2010||December 1, 2017||
† Study has passed its completion date and status has not been verified in more than two years.